Find latest Uterine / Endometrial Cancer videos · 100+ videos

SGO 2024 Insights: "RUBY Part 1 & Part 2 Trial - Dostarlimab + Chemo for Primary Advanced/Recurrent Endometrial Cancer & PARPi Maintenance in Patients Receiving Dostarlimab + Chemo"

485 views
April 9, 2024

Chapters

Background and Key Results from RUBY Part 1

00:00

Advancements in RUBY Part 2

05:55

Safety and Adverse Events

09:40

Comments 0
Login to view comments. Click here to Login